A single-center, multi-factor, retrospective study to improve the diagnostic accuracy of primary prostate cancer using [<sup>68</sup>Ga]Ga-PSMA-11 total-body PET/CT imaging.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 37940684.
- Also identified by DOI 10.1007/s00259-023-06464-1.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To improve the diagnostic accuracy of initial detection in patients with suspected primary prostate cancer (PCa). Eighty-four patients who underwent Gallium-68-labeled prostate-specific membrane antigen ([<sup>68</sup>Ga]Ga-PSMA-11) total-body positron emission tomography/computed tomography (PET/CT) imaging before treatment in our department were enrolled. The maximum standard uptake value (SUVmax) of the prostate (SUVmax-PSMA), liver (SUVmax-PSMA-L), and mediastinal blood pool (SUVmax-PSMA-M) was measured using [<sup>68</sup>Ga]Ga-PSMA-11 total-body PET/CT imaging. The [<sup>68</sup>Ga]Ga-PSMA-11 derived metabolic tumor volume (MTV), the total lesion (TLP), and the cross-sectional areas of focal concentration in the prostate (CAP) were also determined. Besides, the prostate-specific antigen (PSA) levels and the above imaging characteristics were analyzed using receiver operating characteristic curves to identify the cutoff value to improve the diagnostic accuracy of suspected PCa. Finally, a multivariate regression analysis was conducted to discover the independent predictor to improve the diagnostic accuracy on [<sup>68</sup>Ga]Ga-PSMA-11 total-body imaging. There was no significant difference between the PCa and Non-PCa groups in age, height, weight, injected dose, except for the PSA levels, the SUVmax-PSMA, TLP, MTV, and CAP. Besides, the SUVmax-PSMA-T/L and SUVmax-PSMA-T/M derived from SUVmax-PSMA were both significantly different. In addition, the areas under the curve of PSA levels, SUVmax-PSMA, SUVmax-PSMA-T/L, SUVmax-PSMA-T/M, TLP, MTV, and CAP to predict PCa on [<sup>68</sup>Ga]Ga-PSMA-11 imaging were 0.620 (95% confidence interval (CI) 0.485-0.755), 0.864 (95% CI 0.757-0.972), 0.819 (95% CI 0.704-0.935), 0.876 (95% CI 0.771-0.980), 0.845 (95% CI 0.741-0.949), 0.820 (95% CI 0.702-0.938), 0.627 (95% CI 0.499-0.754), respectively. However, a multivariate regression analysis showed that SUVmax-PSMA was an independent predictor, with a cutoff value of 11.5 and an odds ratio of 1.221. The SUVmax-PSMA with a cutoff value of 11.5 was an independent predictor to improve the diagnostic accuracy of PCa on [<sup>68</sup>Ga]Ga-PSMA-11 total-body imaging.
Medical subject headings
- Gallium Radioisotopes
- Prostatic Neoplasms
- Gallium Isotopes